Analogic Corp. (ALOG) CEO James W. Green Sells 2,000 Shares
Analogic Corp. (NASDAQ:ALOG) CEO James W. Green sold 2,000 shares of the company’s stock in a transaction dated Monday, October 10th. The stock was sold at an average price of $88.34, for a total value of $176,680.00. Following the sale, the chief executive officer now owns 36,531 shares in the company, valued at approximately $3,227,148.54. The sale was disclosed in a filing with the SEC, which is available through the SEC website.
Analogic Corp. (NASDAQ:ALOG) opened at 85.59 on Thursday. Analogic Corp. has a 12-month low of $68.71 and a 12-month high of $94.39. The stock has a 50 day moving average price of $89.33 and a 200-day moving average price of $83.72. The stock has a market cap of $1.06 billion, a P/E ratio of 89.16 and a beta of 0.92.
Analogic Corp. (NASDAQ:ALOG) last issued its quarterly earnings data on Wednesday, September 21st. The company reported $1.02 EPS for the quarter, missing the Zacks’ consensus estimate of $1.17 by $0.15. The company had revenue of $138.10 million for the quarter, compared to analyst estimates of $139.03 million. Analogic Corp. had a return on equity of 7.33% and a net margin of 2.38%. The company’s revenue for the quarter was down 10.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.28 EPS. On average, equities analysts expect that Analogic Corp. will post $4.04 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, October 12th. Shareholders of record on Thursday, September 1st were paid a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a dividend yield of 0.47%. The ex-dividend date was Wednesday, September 28th. Analogic Corp.’s dividend payout ratio is presently 41.24%.
Several hedge funds and other institutional investors have recently modified their holdings of the company. Vanguard Group Inc. raised its stake in shares of Analogic Corp. by 4.4% in the second quarter. Vanguard Group Inc. now owns 1,017,011 shares of the company’s stock worth $80,791,000 after buying an additional 43,109 shares during the last quarter. BlackRock Fund Advisors raised its stake in shares of Analogic Corp. by 6.2% in the second quarter. BlackRock Fund Advisors now owns 860,775 shares of the company’s stock worth $68,380,000 after buying an additional 50,566 shares during the last quarter. Silvercrest Asset Management Group LLC raised its stake in shares of Analogic Corp. by 12.2% in the second quarter. Silvercrest Asset Management Group LLC now owns 656,052 shares of the company’s stock worth $52,116,000 after buying an additional 71,192 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Analogic Corp. by 5.7% in the second quarter. Dimensional Fund Advisors LP now owns 635,169 shares of the company’s stock worth $50,458,000 after buying an additional 34,287 shares during the last quarter. Finally, Royce & Associates LP raised its stake in shares of Analogic Corp. by 2.5% in the second quarter. Royce & Associates LP now owns 580,101 shares of the company’s stock worth $46,083,000 after buying an additional 14,400 shares during the last quarter. Institutional investors own 99.81% of the company’s stock.
Several brokerages have weighed in on ALOG. Zacks Investment Research downgraded Analogic Corp. from a “hold” rating to a “sell” rating in a report on Tuesday, September 27th. Brean Capital restated a “buy” rating and set a $100.00 price target (up previously from $90.00) on shares of Analogic Corp. in a report on Thursday, September 22nd.
Analogic Corp. Company Profile
Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies to advance the practice of medicine and save lives. The Company operates through three business segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.
Receive News & Stock Ratings for Analogic Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic Corp. and related stocks with our FREE daily email newsletter.